| Product Code: ETC7052833 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Egypt Parkinsons Disease Market Overview |
3.1 Egypt Country Macro Economic Indicators |
3.2 Egypt Parkinsons Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Egypt Parkinsons Disease Market - Industry Life Cycle |
3.4 Egypt Parkinsons Disease Market - Porter's Five Forces |
3.5 Egypt Parkinsons Disease Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Egypt Parkinsons Disease Market Revenues & Volume Share, By Medical Devices, 2021 & 2031F |
3.7 Egypt Parkinsons Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Egypt Parkinsons Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 Egypt Parkinsons Disease Market Revenues & Volume Share, By Patient Care Setting, 2021 & 2031F |
4 Egypt Parkinsons Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about Parkinson's disease in Egypt |
4.2.2 Growing elderly population in Egypt |
4.2.3 Advances in medical technology leading to better diagnosis and treatment options |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare facilities in Egypt |
4.3.2 High cost of Parkinson's disease treatment and medication |
4.3.3 Stigma associated with neurological disorders in Egyptian society |
5 Egypt Parkinsons Disease Market Trends |
6 Egypt Parkinsons Disease Market, By Types |
6.1 Egypt Parkinsons Disease Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Egypt Parkinsons Disease Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Egypt Parkinsons Disease Market Revenues & Volume, By Levodopa/Carbidopa, 2021- 2031F |
6.1.4 Egypt Parkinsons Disease Market Revenues & Volume, By Dopamine Receptor Agonists, 2021- 2031F |
6.1.5 Egypt Parkinsons Disease Market Revenues & Volume, By MAO-Inhibitors, 2021- 2031F |
6.1.6 Egypt Parkinsons Disease Market Revenues & Volume, By COMT-Inhibitors, 2021- 2031F |
6.1.7 Egypt Parkinsons Disease Market Revenues & Volume, By Anticholinergics, 2021- 2031F |
6.1.8 Egypt Parkinsons Disease Market Revenues & Volume, By Other Drugs, 2021- 2031F |
6.2 Egypt Parkinsons Disease Market, By Medical Devices |
6.2.1 Overview and Analysis |
6.2.2 Egypt Parkinsons Disease Market Revenues & Volume, By Deep Brain Stimulation (DBS) Devices, 2021- 2031F |
6.2.3 Egypt Parkinsons Disease Market Revenues & Volume, By Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices, 2021- 2031F |
6.3 Egypt Parkinsons Disease Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Egypt Parkinsons Disease Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Egypt Parkinsons Disease Market Revenues & Volume, By Transdermal, 2021- 2031F |
6.3.4 Egypt Parkinsons Disease Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.5 Egypt Parkinsons Disease Market Revenues & Volume, By Intestinal Infusion, 2021- 2031F |
6.3.6 Egypt Parkinsons Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Egypt Parkinsons Disease Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Egypt Parkinsons Disease Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Egypt Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Egypt Parkinsons Disease Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.5 Egypt Parkinsons Disease Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.5 Egypt Parkinsons Disease Market, By Patient Care Setting |
6.5.1 Overview and Analysis |
6.5.2 Egypt Parkinsons Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Egypt Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
7 Egypt Parkinsons Disease Market Import-Export Trade Statistics |
7.1 Egypt Parkinsons Disease Market Export to Major Countries |
7.2 Egypt Parkinsons Disease Market Imports from Major Countries |
8 Egypt Parkinsons Disease Market Key Performance Indicators |
8.1 Number of Parkinson's disease awareness campaigns conducted annually |
8.2 Percentage increase in geriatric population in Egypt |
8.3 Adoption rate of new diagnostic tools and treatment methods in Parkinson's disease management |
9 Egypt Parkinsons Disease Market - Opportunity Assessment |
9.1 Egypt Parkinsons Disease Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Egypt Parkinsons Disease Market Opportunity Assessment, By Medical Devices, 2021 & 2031F |
9.3 Egypt Parkinsons Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Egypt Parkinsons Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 Egypt Parkinsons Disease Market Opportunity Assessment, By Patient Care Setting, 2021 & 2031F |
10 Egypt Parkinsons Disease Market - Competitive Landscape |
10.1 Egypt Parkinsons Disease Market Revenue Share, By Companies, 2024 |
10.2 Egypt Parkinsons Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here